Publications by authors named "Daniel M Huse"

Claim this Profile
C
Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors.
Charles D Blanke, Daniel M Huse

J Med Econ· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours.
Daniel M Huse, Margaret von Mehren, Gregory Lenhart, Heikki Joensuu, Charles Blanke

Clin Drug Investig· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A projection of the impact of lipid-lowering therapy on high-risk employee disability and medical costs.
Xue Song, Daniel M Huse, Setareh A Williams, Gerald M Borok, Ken McDonough

J Occup Environ Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Daniel M Huse, Xue Song, Ronald J Ozminkowski, Jonathan Maguire, Setareh A Williams

Clin Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of initial pharmacotherapy for Parkinson's disease in the United States.
Daniel M Huse, Jane Castelli-Haley, Lucinda S Orsini, Gregory Lenhart, Judith A Abdalla

J Geriatr Psychiatry Neurol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness in Parkinson's disease.
Daniel M Huse, Kathy Schulman, Lucinda Orsini, Jane Castelli-Haley, Sean Kennedy

Mov Disord· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis.
Gurkirpal Singh, Jeffrey D Miller, Daniel M Huse, Dan Pettitt, Ralph B D'Agostino

J Rheumatol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
Daniel A Ollendorf, Anna N Peterson, Joseph Doyle, Daniel M Huse

Am J Manag Care· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
Daniel M Huse, Gordon Cummins, Douglas C A Taylor, Mason W Russell

Am J Manag Care· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.
Mason W Russell, Douglas C A Taylor, Gordon Cummins, Daniel M Huse

Am J Manag Care· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis